SEC Form 4 · accession 0001209191-16-135912
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Salameh
Officer — Chief Operating Officer
Period of report
Aug 4, 2016
Accepted (ET)
Aug 8, 2016 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 4, 2016 | M | 100 | $1.08 | A | 11,515 | D | |
| Common StockF2 | Aug 4, 2016 | S | 100 | $2.51 | D | 11,415 | D | |
| Common StockF3 | holding | — | — | — | 1,297 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $1.08 | Aug 4, 2016 | M | 100 | D | — | Jun 30, 2018 | Common Stock | 100 | 72,400 | D |
Explanation of responses
- F1The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective June 14, 2016.
- F2The total securities reflects the transfer of all rights and ownership interest in and to 9,006 shares (or 50% of the total beneficially owned) to the Reporting Person's ex-wife effective December 10, 2015, and the acquisition of 750 shares and 1,659 shares on February 1 and August 1, 2016, respectively, through participation in the Issuer's 2015 Employee Stock Purchase Plan.
- F3Represents the acquisition of 667 and 630 shares on February 1 and August 1, 2016, respectively, by the Reporting Person's spouse through her participation in the Issuer's 2015 Employee Stock Purchase Plan, for which the Reporting Person disclaims beneficial ownership.
- F4The option is fully exercisable as of the date hereof.